Dechra shares fall on tough prior year comps and second half weighting
- Shares fall on tough Q3 comps and 2H weighting- Dechra expects to meet 2023 full-year expectations- De-rating continues against rising rate backdropGlobal veterinary pharmaceutical specialist Dechra Pharmaceuticals (DPH) was the...
20 October 2022